BNAI Q3 2025 Earnings EPS Beat Mitigates Revenue Absence Stock Declines 367 TSAT Q1 2026 Earnings Significant EPS Miss as Revenue Details Remain Unavailable Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Crown Holdings CCK Q1 2026 Earnings EPS Surpasses Expectations with 643 Beat EPC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction KMB Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance